/cloudfront-us-east-2.images.arcpublishing.com/reuters/OQUAQWOLTVPWHKKV5V5M7EYVTY.jpg)
[ad_1]
A logo of Chinese vaccine specialist CanSino Biologics Inc is pictured at the company’s headquarters in Tianjin, following an outbreak of coronavirus disease (COVID-19), in China on August 17, 2020. REUTERS / Thomas Peter
SAO PAULO, Oct. 1 (Reuters) – Brazilian biotechnology company Biomm SA (BIOM3.SA) has signed an exclusive agreement to distribute the COVID-19 vaccine from Cansino Biologics (6185.HK) in Brazil, a dossier of securities.
Biomm said the deal includes potential production of the vaccine at its plant in Minas Gerais. The company will send Brazilian health authority Anvisa a new requirement for emergency use of Cansino’s vaccine in Brazil.
Reporting by Carolina Mandl; edited by Jason Neely
Our Standards: Thomson Reuters Trust Principles.
Source link
